KYNLiV Inc.

Immunotherapeutic Drug Discovery

Kindness for Life

Welcome to KYNLiV

At KYNLiV, we are revolutionizing the field of immunotherapy by developing cutting-edge treatments that target autoimmunity and cancer without compromising the immune system's natural defense mechanisms. Our therapies reprogram disease-associated immune cells to selectively suppress harmful responses, while preserving overall immune function. This innovative approach brings hope to millions suffering from immune-related disorders and cancers, offering a precise and organ-specific treatment that transforms the medical landscape.

What We Do

Our focus is to pioneer immunotherapeutic treatments that restore balance to the immune system. We are driven by science and innovation, and we strive to develop therapies that:

  • Target specific autoimmune disorders and cancers linked to immune dysfunction.
  • Preserve the body's natural defenses, avoiding the common issues of broad immunosuppression that lead to increased risk of infections or other health complications.
  • Provide organ-specific immune regulation, offering patients more effective, targeted treatment options.

We are committed to helping people with chronic immune-related diseases live healthier, fuller lives.

Meet Our Team

Cini Mathew John, PhD, RPh

Director of Management and Research

Chinna Keshavsa Umeshappa, PhD

Director of Scientific Discoveries

Fazlin Fauzi, MPharm, PhD

Chief Scientist, Data and Informatics

Alice Joshua

Strategic Partnership Advisor

Hanna Mathew

Technology Officer

Annette John, MSc

Intern Student

Why KYNLiV?

Autoimmune diseases and cancers present some of the most complex challenges in modern medicine, where the immune system mistakenly attacks the body or fails to eliminate harmful cells. While medical advances have been made, there is no cure for many autoimmune diseases, and current treatments often rely on suppressing the immune system broadly—leading to severe side effects such as heightened risk of infections and even cancer.

At KYNLiV, we recognize the urgent need for more precise treatments, and our therapies aim to deliver the precision and effectiveness required to tackle these diseases at their core, without harmful side effects.